Researchers discover cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Can deep sleep help devastating brain disorders? Scientists studying Parkinson’s want to find out
27 January 2022
Consumer Health: What is a Pap smear, and who needs one?
27 January 2022

Researchers discover cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ceramides in the retina, resulting in progressive photoreceptor cell death and ultimately vision loss. The team also found that a combination of desipramine and L-cycloserine reduced lowered ceramide levels, which protected photoreceptors, helped preserve the retina’s structure and function, and improved vision.

Comments are closed.